Institutional investors hold a majority ownership of RPRX through the 68.09% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Medical Specialties industry. Last, during the quarter ended September 2014, these large investors purchased a net $4.0 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 570.0 Thousand shares of Repros Therapeutics Inc